BioStrand Omics Analysis Blog:
ML

A brief retrospective on our second blogiversary

Dr Ingrid Brands, General Manager | September 21, 2022

It’s been an eventful two years, to the month, since we launched our omics and analysis blog. Our...

AI in Biopharma: Challenges and Opportunities

Dr Ingrid Brands, General Manager | September 14, 2022

There are an estimated novemdecillion, or 1060, molecules in the known universe with potential...

Accelerate Biomarker Discovery with Artificial Intelligence

Dr Ingrid Brands, General Manager | August 31, 2022

Biomarkers play a critical role in realizing the true potential of precision medicine. As accurate...

Closing the Gap of Text and the Biosphere with LENSai™ NLP Link

Dr Ingrid Brands, General Manager | August 17, 2022

Bridging the gap between raw sequence data, secondary research, experimental data, and the...

AI-powered genomics to advance precision medicine

Dr Ingrid Brands, General Manager | July 27, 2022

Sir William Osler, often called the father of modern medicine, was among the first to articulate a ...

Subscribe to our blog

AI, NLP and the ROI of drug development

Dr Ingrid Brands, General Manager | July 20, 2022

The out-of-pocket R&D costs of developing a single drug, whether successfully launched or not, are...

Accelerating pharma R&D and innovation through technology partnerships

Dr Ingrid Brands, General Manager | July 13, 2022

Biopharmas are increasingly turning to alliances & partnerships to drive external innovation....

Improving Drug Safety with Adverse Event Detection Using NLP

Dr Ingrid Brands, General Manager | June 15, 2022

It is estimated that Adverse Events (AEs) are likely one of the 10 leading causes of death and...

A Hybrid Approach to NLP in Drug Discovery

Dr Ingrid Brands, General Manager | June 8, 2022

Artificial Intelligence-powered technologies like NLP are becoming critical to the pharmaceutical...

AI in early phase drug development

Dr Ingrid Brands, General Manager | June 1, 2022

AI technologies are currently the most disruptive trend in the pharmaceutical industry. Over the...

Efficient data integration is the key to effective AI/ML

Dr Ingrid Brands, General Manager | May 18, 2022

AI/ML technologies can be notoriously data-hungry with the broader concern being that certain...